FDA's Drug Review Process and the Package Label: Strategies for Writing Successful FDA Submissions - Image 1

£101.99

Academic Press FDA's Drug Review Process and the Package Label: Strategies for Writing Successful FDA Submissions

Name: FDA's Drug Review Process and the Package Label: Strategies for Writing Successful FDA Submissions
Brand: Academic Press
Price: 96.29 GBP
Availability: InStock

Pharmacy - Dispensing

Price History & Forecast

Last 33 days • 33 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 33 days • 2 price levels

Days at Price

Current Price

Price Analysis

Most common price: £96 (31 days, 93.9%)

Price range: £96 - £102

Price levels: 2 different prices over 33 days

Description

FDA's Drug Review Process and the Package Label provides guidance to pharmaceutical companies for writing FDA-submissions, such as the NDA, BLA, Clinical Study Reports, and Investigator's Brochures. The book provides guidance to medical writers for drafting FDA-submissions in a way more likely to persuade FDA reviewers to grant approval of the drug. In detail, the book reproduces data on efficacy and safety from one hundred different FDA-submissions (NDAs, BLAs). The book reproduces comments and complaints from FDA reviewers regarding data that are fragmentary, ambiguous, or that detract from the drug's approvability, and the book reveals how sponsors overcame FDA's concerns and how sponsors succeeded in persuading FDA to grant approval of the drug. The book uses the most reliable and comprehensive source of information available for writing FDA-submissions, namely text and data from NDAs and BLAs, as published on FDA's website. The source material for writing this book included about 80,000 pages from FDA's Medical Reviews, FDA's Clinical Pharmacology Reviews, and FDA's Pharmacology Reviews, from one hundred different NDAs or BLAs for one hundred different drugs. Each chapter focuses on a different section of the package label, e.g., the Dosage and Administration section or the Drug Interactions section, and demonstrates how the sponsor's data supported that section of the package label. Reveals strategies for winning FDA approval and for drafting the package label Examples are from one hundred FDA-submissions (NDAs, BLAs) for one hundred different drugs, e.g., for oncology, metabolic diseases, autoimmune diseases, and neurological diseases This book uses the most reliable and comprehensive source of information available for writing FDA-submissions, namely, the data from NDAs and BLAs as published on FDA's website at the time FDA grants approval to the drug

Product Specifications

Brand: Academic Press
Format: Paperback
ASIN: 0128146478
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Allied Health Professions > Pharmacy - Dispensing
Domain: Amazon UK
Release Date: 05 December 2017
Listed Since: 02 August 2017

Barcode

No barcode data available

Academic Press FDA's Drug Review Process and the Package Label: Strategies for Writing Successful FDA Submissions

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Guidebook for Drug Regulatory Submissions

Medical Writing in Drug Development: A Practical Guide for Pharmaceutical Research

FDA Regulatory Affairs: A Guide for Prescription Drugs, Medical Devices, and Biologics

An Overview of FDA Regulated Products: From Drugs and Cosmetics to Food and Tobacco

Write It Down: Guidance for Preparing Effective and Compliant Documentation

Contract Research and Development Organizations-Their History, Selection, and Utilization

Wiley - Biological Drug Products: Development and Strategies

Nonclinical Drug Administration: Formulations, Routes and Regimens for Solving Drug Delivery Problems in Animal Model Systems

Regulatory Affairs in the Pharmaceutical Industry

Pharmaceutical Dosage Forms - Parenteral Medications: Volume 1: Formulation and Packaging

FDA Regulatory Affairs: Third Edition

Development and Evaluation of Drugs: From Laboratory through Licensure to Market

Food and Drug Law and Regulation

Pharmaceutical Dosage Forms - Parenteral Medications: Volume 3: Regulations, Validation and the Future

Innovative Statistics in Regulatory Science (Chapman & Hall/CRC Biostatistics Series)

FDA Bioequivalence Standards: 13 (AAPS Advances in the Pharmaceutical Sciences Series, 13)

Targeted Regulatory Writing Techniques: Clinical Documents for Drugs and Biologics

Wiley Analytical Testing for the Pharmaceutical GMP Laboratory

Clinical Trials: Study Design, Endpoints and Biomarkers, Drug Safety, and FDA and ICH Guidelines

Methodologies in Biosimilar Product Development (Chapman & Hall/CRC Biostatistics Series)

Regulated Bioanalytical Laboratories: Technical and Regulatory Aspects from Global Perspectives

Translational ADMET for Drug Therapy: Principles, Methods, and Pharmaceutical Applications

Generic Drug Product Development: Solid Oral Dosage Forms, Second Edition: 129 (Drugs and the Pharmaceutical Sciences)

Basics of Pharmaceutical Manufacturing and Quality Operations: A Comprehensive Guide